{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:00:05Z","timestamp":1790085605789,"version":"4.0.1"},"reference-count":165,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biopha.2026.119850","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T10:13:48Z","timestamp":1786788828000},"page":"119850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hypoxia fuels JAK\/STAT-LIV1 signaling: A promising therapeutic avenue in triple-negative breast cancer"],"prefix":"10.1016","volume":"203","author":[{"given":"Harinivas Manthira","family":"Moorthi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1914-6451","authenticated-orcid":false,"given":"Devi Rajeswari","family":"V","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119850_bib1","unstructured":"WHO, \u201cBreast cancer,\u201d WHO. Accessed: Aug. 17, 2025. [Online]. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer."},{"issue":"3","key":"10.1016\/j.biopha.2026.119850_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2026.119850_bib3","unstructured":"American Cancer Society, \u201cCancer Facts & Figures 2026,\u201d Atlanta, GA, 2026."},{"key":"10.1016\/j.biopha.2026.119850_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2025.102979","article-title":"Understanding female breast cancer risk in the Indian population: Evidence from a systematic review and meta-analysis","volume":"100","author":"Vijayakumar","year":"2026","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.biopha.2026.119850_bib5","series-title":"Breast Cancer","year":"2022"},{"issue":"8","key":"10.1016\/j.biopha.2026.119850_bib6","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1373\/clinchem.2009.125377","article-title":"Understanding resistance to tamoxifen in hormone receptor\u2013positive breast cancer","volume":"55","author":"Higgins","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.biopha.2026.119850_bib7","doi-asserted-by":"crossref","DOI":"10.4137\/CMO.S18006","article-title":"Difference between Luminal A and Luminal B Subtypes According to Ki-67, tumor size, and progesterone receptor negativity providing prognostic information","volume":"8","author":"Inic","year":"2014","journal-title":"Clin. Med. Insights Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119850_bib8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/PAP.0000000000000015","article-title":"HER2 in Breast Cancer","volume":"21","author":"Krishnamurti","year":"2014","journal-title":"Adv. Anat. Pathol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119850_bib9","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1002\/1878-0261.12747","article-title":"Identification and validation of a combined hypoxia and immune index for triple-negative breast cancer","volume":"14","author":"Zheng","year":"2020","journal-title":"Mol. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119850_bib10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10549-013-2461-x","article-title":"The prognostic impact of age in patients with triple-negative breast cancer","volume":"138","author":"Liedtke","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/PPO.0000000000000500","article-title":"Epidemiology of Triple-Negative Breast Cancer","volume":"27","author":"Howard","year":"2021","journal-title":"Cancer J."},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib12","doi-asserted-by":"crossref","first-page":"19107","DOI":"10.1038\/s41598-019-55710-w","article-title":"Molecular stratification within triple-negative breast cancer subtypes","volume":"9","author":"Wang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119850_bib13","first-page":"113","article-title":"Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer","volume":"17","author":"Zhang","year":"2023","journal-title":"Biologics"},{"issue":"2","key":"10.1016\/j.biopha.2026.119850_bib14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/path.4280","article-title":"Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes","volume":"232","author":"Lehmann","year":"2014","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.biopha.2026.119850_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1127704","article-title":"Immunomodulation\u2014a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system","volume":"14","author":"Strzelec","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib17","doi-asserted-by":"crossref","first-page":"11278","DOI":"10.1038\/s41598-024-61640-z","article-title":"Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification","volume":"14","author":"Lee","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119850_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1199105","article-title":"Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens","volume":"13","author":"Srivastava","year":"2023","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119850_bib19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.tips.2017.05.002","article-title":"Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies","volume":"38","author":"Qiu","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2026.119850_bib20","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1136\/gutjnl-2022-327924","article-title":"MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression","volume":"72","author":"Fu","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2026.119850_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1421629","article-title":"Hypoxia-induced epigenetic regulation of breast cancer progression and the tumour microenvironment","volume":"12","author":"Capatina","year":"2024","journal-title":"Front. Cell. Dev. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119850_bib22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/1566524018666181109121849","article-title":"Role of HIF-1 in Cancer Progression: Novel Insights. A Review","volume":"18","author":"Pezzuto","year":"2019","journal-title":"Curr. Mol. Med."},{"issue":"25","key":"10.1016\/j.biopha.2026.119850_bib23","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.2174\/0929867329666220829095334","article-title":"A Comprehensive Description of Hypoxia-inducible Factor 2\u03b1 Inhibitors as Anticancer Agents: A Mini-review","volume":"30","author":"Lu","year":"2023","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119850_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145796","article-title":"Up-down regulation of HIF-1\u03b1 in cancer progression","volume":"798","author":"Rashid","year":"2021","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/jcmm.12004","article-title":"Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells","volume":"17","author":"Mimeault","year":"2013","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41392-023-01679-y","article-title":"Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets","volume":"9","author":"Chen","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/targets4010005","article-title":"Comprehensive Roles of ZIP and ZnT Zinc Transporters in Metabolic Inflammation","volume":"4","author":"Barman","year":"2026","journal-title":"Targets"},{"issue":"11","key":"10.1016\/j.biopha.2026.119850_bib28","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1002\/jcp.30880","article-title":"Zinc transporter LIV1: A promising cell surface target for triple negative breast cancer","volume":"237","author":"Saravanan","year":"2022","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119850_bib29","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.yexcr.2009.10.011","article-title":"Zip6-attenuation promotes epithelial-to-mesenchymal transition in ductal breast tumor (T47D) cells","volume":"316","author":"Lopez","year":"2010","journal-title":"Exp. Cell. Res."},{"issue":"11","key":"10.1016\/j.biopha.2026.119850_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027720","article-title":"LIV-1 Promotes Prostate Cancer Epithelial-to-Mesenchymal Transition and Metastasis through HB-EGF Shedding and EGFR-Mediated ERK Signaling","volume":"6","author":"Lue","year":"2011","journal-title":"PLoS. One"},{"issue":"4","key":"10.1016\/j.biopha.2026.119850_bib31","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.18632\/aging.202452","article-title":"Evaluation of the prognostic values of solute carrier (SLC) family 39 genes for patients with lung adenocarcinoma","volume":"13","author":"Zhou","year":"2021","journal-title":"Aging"},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbrc.2007.08.127","article-title":"LIV-1 suppression inhibits HeLa cell invasion by targeting ERK1\/2-Snail\/Slug pathway","volume":"363","author":"Zhao","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2026.119850_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056542","article-title":"Negative correlation of LIV-1 and E-cadherin expression in hepatocellular carcinoma cells","volume":"8","author":"Shen","year":"2013","journal-title":"PLoS. One"},{"issue":"4","key":"10.1016\/j.biopha.2026.119850_bib34","first-page":"813","article-title":"LIV-1 enhances the aggressive phenotype through the induction of epithelial to mesenchymal transition in human pancreatic carcinoma cells","volume":"35","author":"Unno","year":"2009","journal-title":"Int. J. Oncol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119850_bib35","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.21037\/tcr-20-2640","article-title":"ZIP7 (SLC39A7) expression in colorectal cancer and its correlation with clinical prognosis","volume":"9","author":"Luo","year":"2020","journal-title":"Transl. Cancer Res."},{"issue":"6","key":"10.1016\/j.biopha.2026.119850_bib36","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/ijc.21235","article-title":"Expression levels of the putative zinc transporter LIV-1 are associated with a better outcome of breast cancer patients","volume":"117","author":"Kasper","year":"2005","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2026.119850_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.31203","article-title":"Expression of cell surface zinc transporter LIV1 in triple negative breast cancer is an indicator of poor prognosis and therapy failure","volume":"239","author":"Saravanan","year":"2024","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00404-020-05789-8","article-title":"Zinc distribution within breast cancer tissue of different intrinsic subtypes","volume":"303","author":"Rusch","year":"2021","journal-title":"Arch. Gynecol. Obstet."},{"issue":"6","key":"10.1016\/j.biopha.2026.119850_bib39","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/13543784.2022.2042252","article-title":"Ladiratuzumab vedotin for metastatic triple negative cancer: preliminary results, key challenges, and clinical potential","volume":"31","author":"Rizzo","year":"2022","journal-title":"Expert. Opin. Investig. Drugs"},{"issue":"7","key":"10.1016\/j.biopha.2026.119850_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/nu15071703","article-title":"A Systematic Study on Zinc-Related Metabolism in Breast Cancer","volume":"15","author":"Qu","year":"2023","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.biopha.2026.119850_bib41","doi-asserted-by":"crossref","first-page":"612","DOI":"10.20892\/j.issn.2095-3941.2020.0106","article-title":"Zinc dysregulation in cancers and its potential as a therapeutic target","volume":"17","author":"Wang","year":"2020","journal-title":"Cancer Biol. Med."},{"issue":"7","key":"10.1016\/j.biopha.2026.119850_bib42","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3390\/nu4070648","article-title":"Zinc and Cancer: Implications for LIV-1 in Breast Cancer","volume":"4","author":"Grattan","year":"2012","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1747-1028-5-14","article-title":"Stat3: linking inflammation to epithelial cancer - more than a \u2018gut\u2019 feeling?","volume":"5","author":"Jarnicki","year":"2010","journal-title":"Cell. Div."},{"issue":"11","key":"10.1016\/j.biopha.2026.119850_bib44","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: new and unexpected biological functions","volume":"14","author":"Yu","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2026.119850_bib46","article-title":"Identification of a Hypoxia-Related Molecular Classification and Hypoxic Tumor Microenvironment Signature for Predicting the Prognosis of Patients with Triple-Negative Breast Cancer","volume":"11","author":"Sun","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib47","doi-asserted-by":"crossref","DOI":"10.4252\/wjsc.v18.i1.112278","article-title":"Hypoxia facilitates triple-negative breast cancer stem cells enrichment and stemness maintenance through oxidized ataxia telangiectasia mutated-induced one-carbon metabolism","volume":"18","author":"Yang","year":"2026","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.biopha.2026.119850_bib48","article-title":"Mechanisms of angiogenesis in tumour","volume":"14","author":"Zhang","year":"2024","journal-title":"Front. Oncol."},{"issue":"28","key":"10.1016\/j.biopha.2026.119850_bib49","doi-asserted-by":"crossref","first-page":"9551","DOI":"10.1074\/jbc.RA119.012175","article-title":"Hypoxia drives the assembly of the multienzyme purinosome complex","volume":"295","author":"Doigneaux","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2026.119850_bib50","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s12094-019-02187-8","article-title":"Emerging roles of aerobic glycolysis in breast cancer","volume":"22","author":"Wu","year":"2020","journal-title":"Clin. Transl. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib51","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12935-020-01719-5","article-title":"The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment","volume":"21","author":"Emami Nejad","year":"2021","journal-title":"Cancer Cell. Int."},{"issue":"7","key":"10.1016\/j.biopha.2026.119850_bib52","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.ymthe.2018.05.004","article-title":"Differential but Complementary HIF1\u03b1 and HIF2\u03b1 Transcriptional Regulation","volume":"26","author":"Downes","year":"2018","journal-title":"Mol. Ther."},{"issue":"7565","key":"10.1016\/j.biopha.2026.119850_bib53","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nature14883","article-title":"Structural integration in hypoxia-inducible factors","volume":"524","author":"Wu","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119850_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1328565","article-title":"Hypoxia-adenosine axis as therapeutic targets for acute respiratory distress syndrome","volume":"15","author":"Figarella","year":"2024","journal-title":"Front. Immunol."},{"issue":"37","key":"10.1016\/j.biopha.2026.119850_bib55","doi-asserted-by":"crossref","first-page":"38458","DOI":"10.1074\/jbc.M406026200","article-title":"Differential Function of the Prolyl Hydroxylases PHD1, PHD2, and PHD3 in the Regulation of Hypoxia-inducible Factor","volume":"279","author":"Appelhoff","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"6863","key":"10.1016\/j.biopha.2026.119850_bib56","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/35107085","article-title":"Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression","volume":"414","author":"Makino","year":"2001","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib57","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bbrc.2005.09.038","article-title":"Binding and regulation of hypoxia-inducible factor-1 by the inhibitory PAS proteins","volume":"337","author":"Jang","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2026.119850_bib58","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cpt.2025.07.003","article-title":"Investigating hypoxia-inducible factor signaling in cancer: Mechanisms, clinical implications, targeted therapeutic strategies, and resistance","volume":"4","author":"Shaikat","year":"2026","journal-title":"Cancer Pathog. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2026.119850_bib59","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0959-437X(00)00193-3","article-title":"Activation of the HIF pathway in cancer","volume":"11","author":"Maxwell","year":"2001","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"3","key":"10.1016\/j.biopha.2026.119850_bib60","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.taap.2005.11.006","article-title":"Effects of 12 metal ions on iron regulatory protein 1 (IRP-1) and hypoxia-inducible factor-1 alpha (HIF-1\u03b1) and HIF-regulated genes","volume":"213","author":"Li","year":"2006","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119850_bib61","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00204-023-03483-7","article-title":"The role of hypoxia-inducible factor 1 alpha (HIF-1\u03b1) modulation in heavy metal toxicity","volume":"97","author":"Aschner","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biopha.2026.119850_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2018.00175","article-title":"Hypoxia Mimetic Agents for Ischemic Stroke","volume":"6","author":"Davis","year":"2019","journal-title":"Front. Cell. Dev. Biol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119850_bib63","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1182\/blood-2004-10-3980","article-title":"Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation","volume":"105","author":"Martin","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2026.119850_bib64","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.freeradbiomed.2013.09.001","article-title":"The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: Insights into the potential of various iron therapies to induce oxidative and nitrosative stress","volume":"65","author":"Koskenkorva-Frank","year":"2013","journal-title":"Free. Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.biopha.2026.119850_bib65","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1083\/jcb.200609074","article-title":"The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production","volume":"177","author":"Bell","year":"2007","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.biopha.2026.119850_bib66","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.freeradbiomed.2014.09.015","article-title":"Hypoxia and free radicals: Role in tumor progression and the use of engineering-based platforms to address these relationships","volume":"79","author":"Hielscher","year":"2015","journal-title":"Free. Radic. Biol. Med."},{"issue":"33","key":"10.1016\/j.biopha.2026.119850_bib67","doi-asserted-by":"crossref","first-page":"25130","DOI":"10.1074\/jbc.M001914200","article-title":"Reactive Oxygen Species Generated at Mitochondrial Complex III Stabilize Hypoxia-inducible Factor-1\u03b1 during Hypoxia","volume":"275","author":"Chandel","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.biopha.2026.119850_bib68","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.freeradbiomed.2007.07.001","article-title":"Reactive oxygen species and cellular oxygen sensing","volume":"43","author":"Cash","year":"2007","journal-title":"Free. Radic. Biol. Med."},{"issue":"12","key":"10.1016\/j.biopha.2026.119850_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050165","article-title":"Hypoxia-Induced Aggressiveness of Pancreatic Cancer Cells Is Due to Increased Expression of VEGF, IL-6 and miR-21, Which Can Be Attenuated by CDF Treatment","volume":"7","author":"Bao","year":"2012","journal-title":"PLoS. One"},{"key":"10.1016\/j.biopha.2026.119850_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.866014","article-title":"IL-6\/JAK\/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment","volume":"12","author":"Manore","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2026.119850_bib71","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.12659\/MSM.905418","article-title":"Hypoxia-Induced Activation of JAK\/STAT3 Signaling Pathway Promotes Trophoblast Cell Viability and Angiogenesis in Preeclampsia","volume":"23","author":"Xu","year":"2017","journal-title":"Med. Sci. Monit."},{"issue":"13","key":"10.1016\/j.biopha.2026.119850_bib72","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/onc.2013.115","article-title":"STAT3 and HIF1\u03b1 cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells","volume":"33","author":"Pawlus","year":"2014","journal-title":"Oncogene"},{"issue":"186","key":"10.1016\/j.biopha.2026.119850_bib73","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.24976\/Discov.Med.202436186.129","article-title":"Effects of IL-6R Expression on IL-6\/STAT3\/HIF-1\u03b1 Signaling Pathway in a Mouse Model of Parkinson\u2019s Disease with Type 2 Diabetes Co-Morbidity","volume":"36","author":"Hu","year":"2024","journal-title":"Discov. Med."},{"issue":"19","key":"10.1016\/j.biopha.2026.119850_bib74","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1038\/sj.onc.1208513","article-title":"HIF-1\u03b1, STAT3, CBP\/p300 and Ref-1\/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas","volume":"24","author":"Gray","year":"2005","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib75","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13046-019-1206-z","article-title":"STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review","volume":"38","author":"Qin","year":"2019","journal-title":"J. Exp. & Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119850_bib76","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coi.2015.02.008","article-title":"The IL-6\/gp130\/STAT3 signaling axis: recent advances towards specific inhibition","volume":"34","author":"Garbers","year":"2015","journal-title":"Curr. Opin. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119850_bib77","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119850_bib78","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1042\/BJ20130483","article-title":"A mechanism for epithelial\u2013mesenchymal transition and anoikis resistance in breast cancer triggered by zinc channel ZIP6 and STAT3 (signal transducer and activator of transcription 3","volume":"455","author":"Hogstrand","year":"2013","journal-title":"Biochem. J."},{"issue":"18","key":"10.1016\/j.biopha.2026.119850_bib79","doi-asserted-by":"crossref","first-page":"10120","DOI":"10.1073\/pnas.170192197","article-title":"A Stat3-interacting protein (StIP1) regulates cytokine signal transduction","volume":"97","author":"Collum","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.biopha.2026.119850_bib80","doi-asserted-by":"crossref","first-page":"647","DOI":"10.7150\/thno.16827","article-title":"STAT3\/NF-\u03baB-Regulated Lentiviral TK\/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer","volume":"7","author":"Kuo","year":"2017","journal-title":"Theranostics"},{"issue":"2\u20133","key":"10.1016\/j.biopha.2026.119850_bib81","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12307-018-0218-0","article-title":"Hypoxia Induces the Acquisition of Cancer Stem-like Phenotype Via Upregulation and Activation of Signal Transducer and Activator of Transcription-3 (STAT3) in MDA-MB-231, a Triple Negative Breast Cancer Cell Line","volume":"11","author":"Soleymani Abyaneh","year":"2018","journal-title":"Cancer Microenviron."},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib82","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12943-017-0621-z","article-title":"Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6\/STAT3, Notch and EGFR signaling pathways","volume":"16","author":"Ibrahim","year":"2017","journal-title":"Mol. Cancer"},{"issue":"17","key":"10.1016\/j.biopha.2026.119850_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179188","article-title":"Zinc Favors Triple-Negative Breast Cancer\u2019s Microenvironment Modulation and Cell Plasticity","volume":"22","author":"Vogel-Gonz\u00e1lez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119850_bib84","first-page":"768","article-title":"Zinc: an essential micronutrient","volume":"79","author":"Saper","year":"2009"},{"key":"10.1016\/j.biopha.2026.119850_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101529","article-title":"Zinc at the crossroads of exercise and proteostasis","volume":"35","author":"Hern\u00e1ndez-Camacho","year":"2020","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119850_bib86","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3945\/an.112.003210","article-title":"Discovery of human zinc deficiency: its impact on human health and disease","volume":"4","author":"Prasad","year":"2013","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.biopha.2026.119850_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1750534","article-title":"SLC30 (ZnT) and SLC39 (ZIP) zinc transporter families: from gatekeepers of zinc homeostasis to promoters of tumorigenesis and targets for clinical therapy","volume":"16","author":"Zhou","year":"2026","journal-title":"Front. Immunol."},{"issue":"7\u20138","key":"10.1016\/j.biopha.2026.119850_bib88","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2119\/2007-00040.Taylor","article-title":"The emerging role of the LIV-1 subfamily of zinc transporters in breast cancer","volume":"13","author":"Taylor","year":"2007","journal-title":"Mol. Med."},{"issue":"10","key":"10.1016\/j.biopha.2026.119850_bib89","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1210\/en.2008-0351","article-title":"ZIP7-Mediated Intracellular Zinc Transport Contributes to Aberrant Growth Factor Signaling in Antihormone-Resistant Breast Cancer Cells","volume":"149","author":"Taylor","year":"2008","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.biopha.2026.119850_bib90","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1039\/c9mt00136k","article-title":"Activated zinc transporter ZIP7 as an indicator of anti-hormone resistance in breast cancer","volume":"11","author":"Ziliotto","year":"2019","journal-title":"Metallomics"},{"issue":"5","key":"10.1016\/j.biopha.2026.119850_bib91","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1349-7006.2007.00446.x","article-title":"Zinc and its transporter ZIP10 are involved in invasive behavior of breast cancer cells","volume":"98","author":"Kagara","year":"2007","journal-title":"Cancer Sci."},{"issue":"16","key":"10.1016\/j.biopha.2026.119850_bib92","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1042\/BCJ20160388","article-title":"Zinc transporter ZIP10 forms a heteromer with ZIP6 which regulates embryonic development and cell migration","volume":"473","author":"Taylor","year":"2016","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib93","doi-asserted-by":"crossref","first-page":"40313","DOI":"10.1038\/srep40313","article-title":"A ZIP6-ZIP10 heteromer controls NCAM1 phosphorylation and integration into focal adhesion complexes during epithelial-to-mesenchymal transition","volume":"7","author":"Brethour","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2026.119850_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021255","article-title":"The LIV-1 Subfamily of Zinc Transporters: From Origins to Present Day Discoveries","volume":"24","author":"Taylor","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2026.119850_bib95","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/15216540050033087","article-title":"LIV-1 Breast Cancer Protein Belongs to New Family of Histidine-Rich Membrane Proteins with Potential to Control Intracellular Zn2+ Homeostasis","volume":"49","author":"Taylor","year":"2000","journal-title":"IUBMB Life"},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib96","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1042\/bj20030478","article-title":"Structure\u2013function analysis of LIV-1, the breast cancer-associated protein that belongs to a new subfamily of zinc transporters","volume":"375","author":"Taylor","year":"2003","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.biopha.2026.119850_bib97","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1385\/MB:24:2:157","article-title":"Structural aspects of the metzincin clan of metalloendopeptidases","volume":"24","author":"Gomis-R\u00fcth","year":"2003","journal-title":"Mol. Biotechnol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119850_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030938","article-title":"Prognostic and Predictive Value of LIV1 Expression in Early Breast Cancer and by Molecular Subtype","volume":"15","author":"de Nonneville","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-5793(94)01079-X","article-title":"Families of zinc metalloproteases","volume":"354","author":"Hooper","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2026.119850_bib100","unstructured":"T. Nimmanon, \u201cPost\u2212translational mechanisms of the ZIP family of zinc channels,\u201d 2016."},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib101","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12967-015-0681-z","article-title":"SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma","volume":"13","author":"Cui","year":"2015","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.biopha.2026.119850_bib102","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0959-8049(94)90543-6","article-title":"Oestrogen-regulated genes in breast cancer: Association of pLIV1 with lymph node involvement","volume":"30","author":"Manning","year":"1994","journal-title":"Eur. J. Cancer"},{"issue":"6989","key":"10.1016\/j.biopha.2026.119850_bib103","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature02545","article-title":"Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula organizer","volume":"429","author":"Yamashita","year":"2004","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib104","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1242\/dev.124.1.53","article-title":"Involvement of Sonic hedgehog ( Shh) in mouse embryonic lung growth and morphogenesis,\u201d","volume":"124","author":"Bellusci","year":"1997","journal-title":"Development"},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ydbio.2004.07.039","article-title":"The Drosophila transmembrane protein Fear-of-intimacy controls glial cell migration","volume":"275","author":"Pielage","year":"2004","journal-title":"Dev. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib106","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/humrep\/deh042","article-title":"Menstrual effluent induces epithelial-mesenchymal transitions in mesothelial cells","volume":"19","author":"Demir","year":"2004","journal-title":"Human. Reprod."},{"issue":"2","key":"10.1016\/j.biopha.2026.119850_bib107","first-page":"135","article-title":"Genes that co-cluster with estrogen receptor alpha in microarray analysis of breast biopsies","volume":"1","author":"Dressman","year":"2001","journal-title":"Pharm. J."},{"key":"10.1016\/j.biopha.2026.119850_bib108","unstructured":"S.L., Kelleher and V. Lopez, \u201cLIV-1 and Zn Transporters: Establishing a Link Between Hyperprolactinemia and Breast Cancer.,\u201d 2008."},{"issue":"11","key":"10.1016\/j.biopha.2026.119850_bib109","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1158\/1535-7163.MCT-08-0772","article-title":"Identification of LIV1, a Putative Zinc Transporter Gene Responsible for HDACi-Induced Apoptosis, Using a Functional Gene Screen Approach","volume":"8","author":"Ma","year":"2009","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib110","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/1471-2407-13-326","article-title":"Interrogating differences in expression of targeted gene sets to predict breast cancer outcome","volume":"13","author":"Andres","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2026.119850_bib111","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1016\/j.csbj.2021.07.014","article-title":"Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer","volume":"19","author":"Gy\u0151rffy","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib112","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1590\/1806-9282.63.01.78","article-title":"Zinc and metalloproteinases 2 and 9: What is their relation with breast cancer","volume":"63","author":"do","year":"2017","journal-title":"Rev. Assoc. Med. Bras."},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib113","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41568-024-00763-x","article-title":"The present and future of the Cancer Dependency Map","volume":"25","author":"Arafeh","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2026.119850_bib114","unstructured":"B. DepMap, \u201cDepMap Public 26Q1,\u201d https:\/\/depmap.org\/portal\/."},{"key":"10.1016\/j.biopha.2026.119850_bib115","series-title":"The regulation of LIV-1 mRNA in MDA-MB-231 human breast cancer cells and its association with E-cadherin (CDH1)","author":"Leelyn","year":"2011"},{"issue":"2","key":"10.1016\/j.biopha.2026.119850_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090136","article-title":"High Glucose Level Promotes Migration Behavior of Breast Cancer Cells through Zinc and Its Transporters","volume":"9","author":"Takatani-Nakase","year":"2014","journal-title":"PLoS. One"},{"issue":"2","key":"10.1016\/j.biopha.2026.119850_bib117","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12576-017-0521-4","article-title":"Physiological roles of zinc transporters: molecular and genetic importance in zinc homeostasis","volume":"67","author":"Hara","year":"2017","journal-title":"J. Physiol. Sci."},{"issue":"210","key":"10.1016\/j.biopha.2026.119850_bib118","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2002585","article-title":"Protein Kinase CK2 Triggers Cytosolic Zinc Signaling Pathways by Phosphorylation of Zinc Channel ZIP7","volume":"5","author":"Taylor","year":"2012","journal-title":"Sci. Signal."},{"issue":"5","key":"10.1016\/j.biopha.2026.119850_bib119","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1039\/C6MT00286B","article-title":"Phosphorylation of zinc channel ZIP7 drives MAPK, PI3K and mTOR growth and proliferation signalling","volume":"9","author":"Nimmanon","year":"2017","journal-title":"Metallomics"},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00395-021-00894-4","article-title":"The zinc transporter ZIP7 (Slc39a7) controls myocardial reperfusion injury by regulating mitophagy","volume":"116","author":"Zhang","year":"2021","journal-title":"Basic. Res. Cardiol."},{"key":"10.1016\/j.biopha.2026.119850_bib121","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ygcen.2017.04.016","article-title":"ZIP9, a novel membrane androgen receptor and zinc transporter protein","volume":"257","author":"Thomas","year":"2018","journal-title":"Gen. Comp. Endocrinol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119850_bib122","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1210\/en.2014-1201","article-title":"Identification and Characterization of Membrane Androgen Receptors in the ZIP9 Zinc Transporter Subfamily: II. Role of Human ZIP9 in Testosterone-Induced Prostate and Breast Cancer Cell Apoptosis","volume":"155","author":"Thomas","year":"2014","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.biopha.2026.119850_bib123","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1083\/jcb.200702081","article-title":"Zinc is a novel intracellular second messenger","volume":"177","author":"Yamasaki","year":"2007","journal-title":"J. Cell. Biol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119850_bib124","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1039\/C4MT00086B","article-title":"Zinc ions modulate protein tyrosine phosphatase 1B activity","volume":"6","author":"Bellomo","year":"2014","journal-title":"Metallomics"},{"key":"10.1016\/j.biopha.2026.119850_bib125","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.freeradbiomed.2014.10.851","article-title":"Redox and zinc signalling pathways converging on protein tyrosine phosphatases","volume":"75","author":"Bellomo","year":"2014","journal-title":"Free. Radic. Biol. Med."},{"issue":"11","key":"10.1016\/j.biopha.2026.119850_bib126","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1128\/MCB.23.11.3753-3762.2003","article-title":"Protein Tyrosine Phosphatase 1B Attenuates Growth Hormone-Mediated JAK2-STAT Signaling","volume":"23","author":"Gu","year":"2003","journal-title":"Mol. Cell. Biol."},{"issue":"13","key":"10.1016\/j.biopha.2026.119850_bib127","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.2741\/3051","article-title":"Protein tyrosine phosphatases in the JAK\/STAT pathway","author":"Xu","year":"2008","journal-title":"Front. Biosci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib128","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4049\/jimmunol.2300871","article-title":"A Negative Regulatory Feedback Loop within the JAK\u2013STAT Pathway Mediated by the Protein Tyrosine Phosphatase DUSP14 in Shrimp","volume":"213","author":"Luo","year":"2024","journal-title":"J. Immunol."},{"issue":"13","key":"10.1016\/j.biopha.2026.119850_bib129","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.3390\/nu16132026","article-title":"Emerging Perspectives in Zinc Transporter Research in Prostate Cancer: An Updated Review","volume":"16","author":"Acevedo","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2026.119850_bib130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.freeradbiomed.2013.01.026","article-title":"Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by \u2018antioxidant\u2019 metal chelators: From ferroptosis to stroke","volume":"62","author":"Speer","year":"2013","journal-title":"Free. Radic. Biol. Med."},{"issue":"18","key":"10.1016\/j.biopha.2026.119850_bib131","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1128\/MCB.00090-16","article-title":"The Zinc Finger of Prolyl Hydroxylase Domain Protein 2 Is Essential for Efficient Hydroxylation of Hypoxia-Inducible Factor \u03b1","volume":"36","author":"Arsenault","year":"2016","journal-title":"Mol. Cell. Biol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119850_bib132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015048","article-title":"Zinc Downregulates HIF-1\u03b1 and Inhibits Its Activity in Tumor Cells In Vitro and In Vivo","volume":"5","author":"Nardinocchi","year":"2010","journal-title":"PLoS. One"},{"issue":"4","key":"10.1016\/j.biopha.2026.119850_bib133","doi-asserted-by":"crossref","first-page":"C448","DOI":"10.1152\/ajpcell.00048.2017","article-title":"Cross talk between increased intracellular zinc (Zn 2+) and accumulation of reactive oxygen species in chemical ischemia","volume":"313","author":"Slepchenko","year":"2017","journal-title":"Am. J. Physiol. -Cell. Physiol."},{"key":"10.1016\/j.biopha.2026.119850_bib134","article-title":"Research progress of hypoxia-inducible factor-1\u03b1 and zinc in the mechanism of diabetic kidney disease","volume":"16","author":"Qin","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119850_bib135","article-title":"SLC39A8\/Zinc Suppresses the Progression of Clear Cell Renal Cell Carcinoma","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119850_bib136","doi-asserted-by":"crossref","first-page":"35","DOI":"10.15586\/jkc.v12i4.429","article-title":"Zinc as a Dual-Condition Inhibitor of HIF-1\u03b1\/VEGF-\u03b1\u2013Mediated Angiogenesis in Clear Cell Renal Carcinoma","volume":"12","author":"Carlos","year":"2025","journal-title":"J. Kidney Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib137","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41420-023-01507-w","article-title":"STAT3 and HIF1\u03b1 cooperatively mediate the transcriptional and physiological responses to hypoxia","volume":"9","author":"Dinarello","year":"2023","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.biopha.2026.119850_bib138","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.redox.2016.12.027","article-title":"Zinc deficiency affects the STAT1\/3 signaling pathways in part through redox-mediated mechanisms","volume":"11","author":"Supasai","year":"2017","journal-title":"Redox Biol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119850_bib139","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.31278","article-title":"Exploring the interplay between triple-negative breast cancer stem cells and tumor microenvironment for effective therapeutic strategies","volume":"239","author":"Zou","year":"2024","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib140","first-page":"44","article-title":"Zinc wave during the treatment of hypoxia is required for initial reactive oxygen species activation in mitochondria","volume":"8","author":"Slepchenko","year":"2016","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119850_bib141","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s00018-020-03616-6","article-title":"The ZIP6\/ZIP10 heteromer is essential for the zinc-mediated trigger of mitosis","volume":"78","author":"Nimmanon","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2026.119850_bib142","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.687367","article-title":"Zap70 Regulates TCR-Mediated Zip6 Activation at the Immunological Synapse","volume":"12","author":"Kim","year":"2021","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119850_bib143","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1016\/j.apsb.2021.03.042","article-title":"Antibody\u2013drug conjugates: Recent advances in linker chemistry","volume":"11","author":"Su","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"4_ement","key":"10.1016\/j.biopha.2026.119850_bib144","article-title":"Abstract PD3-14: Phase 1 study of the antibody-drug conjugate SGN-LIV1A in patients with heavily pretreated triple-negative metastatic breast cancer","volume":"78","author":"Modi","year":"2018","journal-title":"Cancer Res."},{"issue":"13_ement","key":"10.1016\/j.biopha.2026.119850_bib145","article-title":"Abstract 2742: Additional mechanisms of action of ladiratuzumab vedotin contribute to increased immune cell activation within the tumor","volume":"78","author":"Cao","year":"2018","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.biopha.2026.119850_bib146","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1158\/1535-7163.MCT-13-0896","article-title":"SGN\u2013LIV1A: A Novel Antibody\u2013Drug Conjugate Targeting LIV-1 for the Treatment of Metastatic Breast Cancer","volume":"13","author":"Sussman","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2026.119850_bib147","unstructured":"Django Sussman, Fu. Li, and Ana Kostic, \u201c Combination therapy using a LIV1-ADC and a chemotherapeutic,\u201d US 11,325,980 B2, May 10, 2022."},{"key":"10.1016\/j.biopha.2026.119850_bib148","unstructured":"ClinicalTrails.gov., \u201cA Safety Study of SGN-LIV1A in Breast Cancer Patients,\u201d ClinicalTrails.gov. Accessed: Oct. 13, 2025. [Online]. Available: https:\/\/clinicaltrials.gov\/study\/NCT01969643."},{"issue":"10","key":"10.1016\/j.biopha.2026.119850_bib149","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.3390\/nu12102993","article-title":"Significant Decreased Expressions of CaN, VEGF, SLC39A6 and SFRP1 in MDA-MB-231 Xenograft Breast Tumor Mice Treated with Moringa oleifera Leaves and Seed Residue (MOLSr) Extracts","volume":"12","author":"Lim","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2026.119850_bib150","unstructured":"ClinicalTrials.gov, \u201cOral STAT3 Inhibitor, TTI-101, in Patients with Advanced Cancers,\u201d https:\/\/clinicaltrials.gov\/study\/NCT03195699."},{"issue":"18","key":"10.1016\/j.biopha.2026.119850_bib151","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1038\/s41388-017-0076-0","article-title":"Novel synthetic bisindolylmaleimide alkaloids inhibit STAT3 activation by binding to the SH2 domain and suppress breast xenograft tumor growth","volume":"37","author":"Li","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119850_bib152","first-page":"9623","article-title":"Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts","volume":"109","author":"Zhang","year":"2012"},{"key":"10.1016\/j.biopha.2026.119850_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.836724","article-title":"Novel STAT3 Inhibitors Targeting STAT3 Dimerization by Binding to the STAT3 SH2 Domain","volume":"13","author":"Hua","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119850_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128338","article-title":"Total synthesis and biological evaluation of 7-hydroxyneolamellarin A as hypoxia-inducible factor-1\u03b1 inhibitor for cancer therapy","volume":"50","author":"Li","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2026.119850_bib155","article-title":"Liposomal formulation of HIF-1\u03b1 inhibitor echinomycin eliminates established metastases of triple-negative breast cancer","volume":"29","author":"Bailey","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2026.119850_bib156","article-title":"Inhibition of Murine Breast Cancer Metastases by Hydrophilic As4S4 Nanoparticles Is Associated With Decreased ROS and HIF-1\u03b1 Downregulation","volume":"9","author":"Wang","year":"2019","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119850_bib157","doi-asserted-by":"crossref","first-page":"11322","DOI":"10.1021\/acs.jmedchem.5c00264","article-title":"Discovery and Characterization of a First-in-Class LIV1-TLR7\/8 Immunomodulatory Conjugate with Robust Myeloid Activation and Antitumor Activity","volume":"68","author":"Yamazoe","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119850_bib158","series-title":"Regular and Young Investigator Award Abstracts","article-title":"324\u2005Allogeneic CAR T cells targeting Liv-1 for breast cancer","author":"Zakas","year":"2023"},{"issue":"1","key":"10.1016\/j.biopha.2026.119850_bib159","first-page":"100","article-title":"Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study","volume":"22","author":"Shah","year":"2023","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.biopha.2026.119850_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101897","article-title":"Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial","volume":"58","author":"Bekaii-Saab","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"4","key":"10.1016\/j.biopha.2026.119850_bib161","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/0284186X.2017.1301680","article-title":"HIF-1 in cancer therapy: two decade long story of a transcription factor","volume":"56","author":"Soni","year":"2017","journal-title":"Acta Oncol. (Madr. )"},{"issue":"6","key":"10.1016\/j.biopha.2026.119850_bib162","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1158\/1078-0432.CCR-24-2920","article-title":"Phase I Trial of TTI-101, a First-in-Class Oral Inhibitor of STAT3, in Patients with Advanced Solid Tumors","volume":"31","author":"Tsimberidou","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119850_bib163","doi-asserted-by":"crossref","DOI":"10.20517\/cdr.2025.148","article-title":"Mechanisms of resistance to antibody-drug conjugates in cancer therapy: molecular basis and therapeutic strategies","author":"Hao","year":"2025","journal-title":"Cancer Drug. Resist."},{"issue":"4","key":"10.1016\/j.biopha.2026.119850_bib164","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyag020","article-title":"Overcoming resistance to antibody-drug conjugates: mechanisms and emerging strategies","volume":"31","author":"Inase","year":"2026","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.biopha.2026.119850_bib165","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1158\/1078-0432.CCR-21-2394","article-title":"18F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition","volume":"28","author":"Reeves","year":"2022","journal-title":"Clin. Cancer Res."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:05:13Z","timestamp":1790082313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226008863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":165,"alternative-id":["S0753332226008863"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119850","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoxia fuels JAK\/STAT-LIV1 signaling: A promising therapeutic avenue in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119850","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119850"}}